Examining Exposure Misclassification of Oral Bisphosphonate Therapy and the Associated Fracture Risk: A Cohort Study

Burden AM^1,2*, Gruneir A^3,4,5, Paterson JM^3,5,6 and Cadarette SM^1,3

¹Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto ON, Canada

²Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands

³Institute for Clinical Evaluative Sciences, Toronto ON, Canada

⁴Women’s College Research Institute, Women’s College Hospital, Toronto ON, Canada

⁵Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto ON, Canada

⁶Department of Family Medicine, McMaster University, Hamilton ON, Canada